Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phenytoin hypersensitivity: 38 cases.

F Haruda

    Neurology
    |November 1, 1979
    PubMed
    Summary

    Hypersensitivity reactions to phenytoin are common, with rashes and fever being most frequent. Early recognition and drug withdrawal are crucial to prevent severe complications from phenytoin sensitivity.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The prospective payment system: a civic good, not a civil war.

    JAMA·1991
    Same author

    Status epilepticus--risks and treatment.

    Pediatrics·1989
    Same author

    "Hip-pocket" sign in the diagnosis of nicotine poisoning.

    Pediatrics·1989
    Same author

    Hemorrhagic infarction after anticoagulant therapy.

    Neurology·1985
    Same author

    Rapid resolution of organic mental syndrome in sickle cell anemia in response to exchange transfusion.

    Neurology·1981
    Same author

    Unrecognized Candida brain abscess in infancy: two cases and a review of the literature.

    The Johns Hopkins medical journal·1980

    Area of Science:

    • Pharmacology
    • Clinical Toxicology
    • Immunology

    Background:

    • Phenytoin is a widely used anticonvulsant medication.
    • Hypersensitivity reactions can occur with phenytoin therapy.
    • Understanding the spectrum and timing of these reactions is important for patient safety.

    Purpose of the Study:

    • To investigate the frequency and severity of hypersensitivity reactions to phenytoin.
    • To characterize the clinical manifestations and timeline of these reactions.
    • To assess the impact of phenytoin hypersensitivity on healthcare utilization.

    Main Methods:

    • Retrospective review of 38 cases with confirmed phenytoin hypersensitivity reactions.
    • Inclusion criteria: patients with reactions solely attributed to phenytoin, excluding concurrent drug use.
    • Data collection focused on reaction types, timing, and patient outcomes.

    Main Results:

    • Rashes were the most common manifestation, followed by fever, lymphadenopathy, and eosinophilia.
    • Other reported reactions included abnormal liver function tests, blood dyscrasias, serum sickness, renal failure, and polymyositis.
    • The pseudolymphoma syndrome (fever, rash, lymphadenopathy) occurred in nine patients, with 35 of 38 reactions appearing within two months of starting phenytoin therapy.

    Conclusions:

    • Phenytoin hypersensitivity reactions present with a diverse range of symptoms, often within the first two months of treatment.
    • Prompt recognition and discontinuation of phenytoin are essential for mitigating serious morbidity.
    • Phenytoin sensitivity contributed significantly to inpatient days, highlighting the clinical and economic burden of these reactions.

    Related Experiment Videos